Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma
Authors
Keywords
Anastrozole, Adenocarcinoma, Aromatase inhibitor, Endometrial cancer, Hormone therapy
Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 293, Issue 4, Pages 701-708
Publisher
Springer Nature
Online
2015-12-15
DOI
10.1007/s00404-015-3974-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
- (2015) Brian M. Slomovitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway
- (2015) Jennifer J. Wheler et al. Oncotarget
- Current opinion on bevacizumab on endometrial cancer treatment
- (2014) Stefano Bogliolo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The therapeutic significance of aromatase inhibitors in endometrial carcinoma
- (2014) Chao Gao et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
- (2014) Don S. Dizon et al. GYNECOLOGIC ONCOLOGY
- Hormone therapy for patients with advanced or recurrent endometrial cancer
- (2014) Wen-Ling Lee et al. Journal of the Chinese Medical Association
- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) N. Colombo et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
- (2013) Per Eystein Lønning et al. ENDOCRINE-RELATED CANCER
- Neoadjuvant treatment of endometrial cancer using anastrozole: A randomised pilot study
- (2013) Amudha Thangavelu et al. GYNECOLOGIC ONCOLOGY
- Adjuvant Treatment of Advanced-stage Endometrial Cancer
- (2011) NITA KARNIK LEE CLINICAL OBSTETRICS AND GYNECOLOGY
- Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
- (2011) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
- (2011) Cornelis JH van de Velde et al. LANCET
- Hematogenous metastases in patients with Stage I or II endometrial carcinoma
- (2011) Paweł Blecharz et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Adjuvant aromatase inhibitor therapy: Outcomes and safety
- (2010) Wolfgang Janni et al. CANCER TREATMENT REVIEWS
- Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma
- (2009) L. C. Barker et al. CURRENT MEDICAL RESEARCH AND OPINION
- Structural basis for androgen specificity and oestrogen synthesis in human aromatase
- (2009) Debashis Ghosh et al. NATURE
- Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole
- (2008) Stefania Bellone et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole
- (2008) Mario Valenzano Menada et al. BREAST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search